Sunday, 25 December 2011

Rofucal




Rofucal may be available in the countries listed below.


Ingredient matches for Rofucal



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Rofucal in the following countries:


  • Mexico

International Drug Name Search

Corinfar




Corinfar may be available in the countries listed below.


Ingredient matches for Corinfar



Nifedipine

Nifedipine is reported as an ingredient of Corinfar in the following countries:


  • Bulgaria

  • Czech Republic

  • Estonia

  • Georgia

  • Germany

  • Hungary

  • Latvia

  • Romania

  • Russian Federation

  • Slovakia

International Drug Name Search

Thursday, 15 December 2011

Scopoderm




Scopoderm may be available in the countries listed below.


UK matches:

  • Scopoderm TTS (Novartis Consumer Health) (SPC)

Ingredient matches for Scopoderm



Scopolamine

Scopolamine is reported as an ingredient of Scopoderm in the following countries:


  • Denmark

  • Finland

  • Iceland

  • Luxembourg

  • Norway

  • Sweden

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 13 December 2011

Galvumet




Galvumet may be available in the countries listed below.


Ingredient matches for Galvumet



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Galvumet in the following countries:


  • Switzerland

Vildagliptin

Vildagliptin is reported as an ingredient of Galvumet in the following countries:


  • Switzerland

International Drug Name Search

Saturday, 10 December 2011

Metosan




Metosan may be available in the countries listed below.


Ingredient matches for Metosan



Meloxicam

Meloxicam is reported as an ingredient of Metosan in the following countries:


  • Austria

International Drug Name Search

Friday, 2 December 2011

Roxiden




Roxiden may be available in the countries listed below.


Ingredient matches for Roxiden



Piroxicam

Piroxicam is reported as an ingredient of Roxiden in the following countries:


  • Italy

International Drug Name Search

Thursday, 24 November 2011

Lovatex




Lovatex may be available in the countries listed below.


Ingredient matches for Lovatex



Lovastatin

Lovastatin is reported as an ingredient of Lovatex in the following countries:


  • Greece

International Drug Name Search

Wednesday, 23 November 2011

Eritromagis




Eritromagis may be available in the countries listed below.


Ingredient matches for Eritromagis



Erythromycin

Erythromycin propionate (a derivative of Erythromycin) is reported as an ingredient of Eritromagis in the following countries:


  • Romania

International Drug Name Search

Tuesday, 22 November 2011

Ribostamicina




Ribostamicina may be available in the countries listed below.


Ingredient matches for Ribostamicina



Ribostamycin

Ribostamicina (DCIT) is also known as Ribostamycin (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 13 November 2011

Tiamina




Tiamina may be available in the countries listed below.


Ingredient matches for Tiamina



Thiamine

Tiamina (DCIT) is known as Thiamine in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Roxitromycine




Roxitromycine may be available in the countries listed below.


Ingredient matches for Roxitromycine



Roxithromycin

Roxithromycin is reported as an ingredient of Roxitromycine in the following countries:


  • Netherlands

International Drug Name Search

Wednesday, 9 November 2011

Glasel




Glasel may be available in the countries listed below.


Ingredient matches for Glasel



Etofenamate

Etofenamate is reported as an ingredient of Glasel in the following countries:


  • Germany

International Drug Name Search

Tuesday, 8 November 2011

Supracalm




Supracalm may be available in the countries listed below.


Ingredient matches for Supracalm



Paracetamol

Paracetamol is reported as an ingredient of Supracalm in the following countries:


  • Chile

  • Peru

International Drug Name Search

Thursday, 27 October 2011

Nikameal




Nikameal may be available in the countries listed below.


Ingredient matches for Nikameal



Nisoldipine

Nisoldipine is reported as an ingredient of Nikameal in the following countries:


  • Japan

International Drug Name Search

Sunday, 23 October 2011

Lisinopril Ecapril




Lisinopril Ecapril may be available in the countries listed below.


Ingredient matches for Lisinopril Ecapril



Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Ecapril in the following countries:


  • Portugal

International Drug Name Search

Sunday, 16 October 2011

Kalcipos-D




Kalcipos-D may be available in the countries listed below.


Ingredient matches for Kalcipos-D



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Kalcipos-D in the following countries:


  • Sweden

Colecalciferol

Colecalciferol is reported as an ingredient of Kalcipos-D in the following countries:


  • Sweden

International Drug Name Search

Sunday, 9 October 2011

Adronat




Adronat may be available in the countries listed below.


Ingredient matches for Adronat



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Adronat in the following countries:


  • Australia

  • Italy

  • Portugal

International Drug Name Search

Saturday, 8 October 2011

Perskindol Ibuprofen akut




Perskindol Ibuprofen akut may be available in the countries listed below.


Ingredient matches for Perskindol Ibuprofen akut



Ibuprofen

Ibuprofen lysine (a derivative of Ibuprofen) is reported as an ingredient of Perskindol Ibuprofen akut in the following countries:


  • Switzerland

International Drug Name Search

Vitamin B1 Ethica




Vitamin B1 Ethica may be available in the countries listed below.


Ingredient matches for Vitamin B1 Ethica



Thiamine

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Vitamin B1 Ethica in the following countries:


  • Indonesia

International Drug Name Search

Sunday, 2 October 2011

Vicalvit D




Vicalvit D may be available in the countries listed below.


Ingredient matches for Vicalvit D



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Vicalvit D in the following countries:


  • Poland

Colecalciferol

Colecalciferol is reported as an ingredient of Vicalvit D in the following countries:


  • Poland

International Drug Name Search

Saturday, 1 October 2011

Tromagesic




Tromagesic may be available in the countries listed below.


Ingredient matches for Tromagesic



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Tromagesic in the following countries:


  • India

International Drug Name Search

Friday, 30 September 2011

Davercin




Davercin may be available in the countries listed below.


Ingredient matches for Davercin



Erythromycin

Erythromycin is reported as an ingredient of Davercin in the following countries:


  • Bulgaria

  • Hungary

  • Poland

International Drug Name Search

Monday, 26 September 2011

Largactil




Largactil may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Largactil Injection (SPC)

Ingredient matches for Largactil



Chlorpromazine

Chlorpromazine is reported as an ingredient of Largactil in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Iceland

  • Nicaragua

  • Panama

  • Serbia

  • Tunisia

  • Turkey

Chlorpromazine hydrochloride (a derivative of Chlorpromazine) is reported as an ingredient of Largactil in the following countries:


  • Australia

  • Bangladesh

  • Chile

  • France

  • Ghana

  • Greece

  • Italy

  • Kenya

  • Mexico

  • New Zealand

  • Nigeria

  • Oman

  • Portugal

  • Spain

  • United Kingdom

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 23 September 2011

Roximerck




Roximerck may be available in the countries listed below.


Ingredient matches for Roximerck



Roxithromycin

Roxithromycin is reported as an ingredient of Roximerck in the following countries:


  • Japan

International Drug Name Search

Zopranol Diu




Zopranol Diu may be available in the countries listed below.


Ingredient matches for Zopranol Diu



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Zopranol Diu in the following countries:


  • Spain

Zofenopril

Zofenopril calcium salt (a derivative of Zofenopril) is reported as an ingredient of Zopranol Diu in the following countries:


  • Spain

International Drug Name Search

Thursday, 22 September 2011

Assonax




Assonax may be available in the countries listed below.


Ingredient matches for Assonax



Naproxen

Naproxen is reported as an ingredient of Assonax in the following countries:


  • Peru

International Drug Name Search

Tuesday, 13 September 2011

Klodin




Klodin may be available in the countries listed below.


Ingredient matches for Klodin



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Klodin in the following countries:


  • Italy

International Drug Name Search

Saturday, 10 September 2011

Metformina Cinfa




Metformina Cinfa may be available in the countries listed below.


Ingredient matches for Metformina Cinfa



Metformin

Metformin is reported as an ingredient of Metformina Cinfa in the following countries:


  • Portugal

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformina Cinfa in the following countries:


  • Spain

International Drug Name Search

Quinidine Bisulphate




Quinidine Bisulphate may be available in the countries listed below.


Ingredient matches for Quinidine Bisulphate



Quinidine

Quinidine Bisulphate (BANM) is known as Quinidine in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 7 September 2011

Altana Albothyl




Altana Albothyl may be available in the countries listed below.


Ingredient matches for Altana Albothyl



Policresulen

Policresulen is reported as an ingredient of Altana Albothyl in the following countries:


  • Vietnam

International Drug Name Search

Tuesday, 6 September 2011

Ruxid




Ruxid may be available in the countries listed below.


Ingredient matches for Ruxid



Roxithromycin

Roxithromycin is reported as an ingredient of Ruxid in the following countries:


  • Bahrain

  • Iraq

  • Jordan

  • Libya

  • Oman

  • Qatar

  • Saudi Arabia

  • Sudan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Saturday, 3 September 2011

Ribasphere




In the US, Ribasphere (ribavirin systemic) is a member of the following drug classes: inhaled anti-infectives, purine nucleosides and is used to treat Hepatitis C.

US matches:

  • Ribasphere

  • Ribasphere Capsules

  • Ribasphere Ribapak

  • Ribasphere Tablets

Ingredient matches for Ribasphere



Ribavirin

Ribavirin is reported as an ingredient of Ribasphere in the following countries:


  • Turkey

  • United States

International Drug Name Search

Eutha Naze




Eutha Naze may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Eutha Naze



Pentobarbital

Pentobarbital sodium salt (a derivative of Pentobarbital) is reported as an ingredient of Eutha Naze in the following countries:


  • South Africa

International Drug Name Search

Monday, 22 August 2011

Ovoplex




Ovoplex may be available in the countries listed below.


Ingredient matches for Ovoplex



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Ovoplex in the following countries:


  • Spain

Levonorgestrel

Levonorgestrel is reported as an ingredient of Ovoplex in the following countries:


  • Spain

International Drug Name Search

Saturday, 20 August 2011

Betamethasone/Calcipotriene Suspension


Pronunciation: BAY-ta-METH-a-sone/KAL-si-poe-TRYE-een
Generic Name: Betamethasone/Calcipotriene
Brand Name: Taclonex Scalp


Betamethasone/Calcipotriene Suspension is used for:

Treating a certain type of psoriasis (psoriasis vulgaris) on the scalp. It may also be used for other conditions as determined by your doctor.


Betamethasone/Calcipotriene Suspension is a combination of a topical corticosteroid and an agent that is similar to vitamin D. Exactly how it works to treat psoriasis is not known.


Do NOT use Betamethasone/Calcipotriene Suspension if:


  • you are allergic to any ingredient in Betamethasone/Calcipotriene Suspension

  • you have a known or suspected calcium metabolism disorder, high levels of calcium or vitamin D in the blood, or high levels of calcium in the urine

  • you have certain other types of psoriasis (erythrodermic, exfoliative, pustular)

  • you have thin skin or a skin infection on the scalp

  • you have severe kidney or liver disease

Contact your doctor or health care provider right away if any of these apply to you.



Before using Betamethasone/Calcipotriene Suspension:


Some medical conditions may interact with Betamethasone/Calcipotriene Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have liver or kidney problems or kidney stones

  • if you have diabetes

  • if you have any cuts, scrapes, or lessened blood flow to your skin

  • if you have had a recent vaccination; have measles, tuberculosis, chickenpox, or shingles; have an infection; or have had a positive tuberculosis test

  • if you are taking prednisone or a similar medicine, or you are having any kind of phototherapy treatment for psoriasis

Some MEDICINES MAY INTERACT with Betamethasone/Calcipotriene Suspension. Because little, if any, of Betamethasone/Calcipotriene Suspension is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Betamethasone/Calcipotriene Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Betamethasone/Calcipotriene Suspension:


Use Betamethasone/Calcipotriene Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Betamethasone/Calcipotriene Suspension. Talk to your pharmacist if you have questions about this information.

  • Shake well before each use.

  • Wash your hands before and after using Betamethasone/Calcipotriene Suspension

  • Apply a small amount of medicine to the affected area on the scalp and gently rub it in.

  • Do not bandage or cover the treated skin area unless directed by your doctor.

  • Do not wash your hair right after you apply Betamethasone/Calcipotriene Suspension.

  • Do not apply Betamethasone/Calcipotriene Suspension within 12 hours before or after any chemical treatments to your hair.

  • If you miss a dose of Betamethasone/Calcipotriene Suspension, apply it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply 2 doses at once.

Ask your health care provider any questions you may have about how to use Betamethasone/Calcipotriene Suspension.



Important safety information:


  • Betamethasone/Calcipotriene Suspension is for external use only. Do not get Betamethasone/Calcipotriene Suspension in the eyes, nose, or mouth. If you get Betamethasone/Calcipotriene Suspension in your eyes or on your face, rinse immediately with cool water.

  • Do NOT use more than the recommended dose or use for longer than 8 weeks without checking with your doctor.

  • Betamethasone/Calcipotriene Suspension is for use on the scalp only. Do not use Betamethasone/Calcipotriene Suspension on the face, under your arms, or on your groin.

  • Betamethasone/Calcipotriene Suspension may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Betamethasone/Calcipotriene Suspension. Use a sunscreen or wear a hat if you must be outside for more than a short time.

  • Talk with your doctor before you receive any vaccine while using Betamethasone/Calcipotriene Suspension.

  • Talk with your doctor before you use any other medicines or cleansers on your skin.

  • Betamethasone/Calcipotriene Suspension has a corticosteroid in it. Before you start any new medicine, check the label to see if it has a corticosteroid in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Lab tests, including blood calcium level and adrenal gland function, may be performed while you use Betamethasone/Calcipotriene Suspension. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Betamethasone/Calcipotriene Suspension should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

  • Corticosteroids may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they use Betamethasone/Calcipotriene Suspension.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Betamethasone/Calcipotriene Suspension while you are pregnant. It is not known if Betamethasone/Calcipotriene Suspension is found in breast milk after topical use. If you are or will be breast-feeding while you use Betamethasone/Calcipotriene Suspension, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Betamethasone/Calcipotriene Suspension:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Mild burning, itching, pain, or redness at the application site.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); acne-like rash; confusion; eye irritation; increased thirst or urination; inflamed hair pores; muscle weakness; persistent headache; severe burning, cracking, irritation, redness, or peeling skin not present before you began using Betamethasone/Calcipotriene Suspension; severe or persistent dizziness, drowsiness, or weakness; severe or persistent vomiting; thinning, softening, or discoloration of the skin; unusual or easy bruising; unusual weight gain, especially in the face.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Betamethasone/Calcipotriene side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include increased thirst or urination; muscle weakness; unusual weight gain, especially in the face.


Proper storage of Betamethasone/Calcipotriene Suspension:

Store Betamethasone/Calcipotriene Suspension at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Do not refrigerate. Store away from heat, moisture, and light. Use within 3 months after opening. Keep Betamethasone/Calcipotriene Suspension out of the reach of children and away from pets.


General information:


  • If you have any questions about Betamethasone/Calcipotriene Suspension, please talk with your doctor, pharmacist, or other health care provider.

  • Betamethasone/Calcipotriene Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Betamethasone/Calcipotriene Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Betamethasone/Calcipotriene resources


  • Betamethasone/Calcipotriene Side Effects (in more detail)
  • Betamethasone/Calcipotriene Use in Pregnancy & Breastfeeding
  • Betamethasone/Calcipotriene Drug Interactions
  • Betamethasone/Calcipotriene Support Group
  • 15 Reviews for Betamethasone/Calcipotriene - Add your own review/rating


Compare Betamethasone/Calcipotriene with other medications


  • Psoriasis

Thursday, 18 August 2011

Relatene




Relatene may be available in the countries listed below.


Ingredient matches for Relatene



Ketoprofen

Ketoprofen is reported as an ingredient of Relatene in the following countries:


  • Chile

International Drug Name Search

Saturday, 13 August 2011

Alopurinol




Alopurinol may be available in the countries listed below.


Ingredient matches for Alopurinol



Allopurinol

Allopurinol is reported as an ingredient of Alopurinol in the following countries:


  • Bosnia & Herzegowina

  • Chile

  • Croatia (Hrvatska)

  • Ecuador

  • Peru

  • Serbia

  • Slovenia

  • Venezuela

International Drug Name Search

Thursday, 11 August 2011

Roxi Basics




Roxi Basics may be available in the countries listed below.


Ingredient matches for Roxi Basics



Roxithromycin

Roxithromycin is reported as an ingredient of Roxi Basics in the following countries:


  • Germany

International Drug Name Search

Wednesday, 10 August 2011

Phenpro AbZ




Phenpro AbZ may be available in the countries listed below.


Ingredient matches for Phenpro AbZ



Phenprocoumon

Phenprocoumon is reported as an ingredient of Phenpro AbZ in the following countries:


  • Germany

International Drug Name Search

Sunday, 7 August 2011

Ambrocol




Ambrocol may be available in the countries listed below.


Ingredient matches for Ambrocol



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ambrocol in the following countries:


  • China

Clenbuterol

Clenbuterol hydrochloride (a derivative of Clenbuterol) is reported as an ingredient of Ambrocol in the following countries:


  • China

International Drug Name Search

Wednesday, 3 August 2011

Rynatan D




Rynatan D may be available in the countries listed below.


Ingredient matches for Rynatan D



Oxymetazoline

Oxymetazoline is reported as an ingredient of Rynatan D in the following countries:


  • Peru

International Drug Name Search

Tuesday, 26 July 2011

Amoxycilline




Amoxycilline may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amoxycilline



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxycilline in the following countries:


  • Netherlands

International Drug Name Search

Comdasin Solution




Comdasin Solution may be available in the countries listed below.


Ingredient matches for Comdasin Solution



Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Comdasin Solution in the following countries:


  • Indonesia

International Drug Name Search

Friday, 22 July 2011

Ramipril Teva




Ramipril-Teva may be available in the countries listed below.


Ingredient matches for Ramipril-Teva



Ramipril

Ramipril is reported as an ingredient of Ramipril-Teva in the following countries:


  • France

  • Germany

  • Israel

  • Latvia

International Drug Name Search

Wednesday, 20 July 2011

ReVital Squeezers Solution


Pronunciation: e-LECK-troe-lite
Generic Name: Electrolyte
Brand Name: ReVital Squeezers


ReVital Squeezers Solution is used for:

Treating or preventing dehydration caused by vomiting or diarrhea. It may also be used for other conditions as determined by your doctor.


ReVital Squeezers Solution is a carbohydrate and electrolyte combination. It works by replacing electrolytes and carbohydrates in the body to prevent dehydration.


Do NOT use ReVital Squeezers Solution if:


  • you are allergic to any ingredient in ReVital Squeezers Solution

  • you have high blood potassium levels

Contact your doctor or health care provider right away if any of these apply to you.



Before using ReVital Squeezers Solution:


Some medical conditions may interact with ReVital Squeezers Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have heart failure, fluid retention (eg, swelling of the hands, ankles, or feet), intestinal holes or punctures, difficulty urinating, kidney problems, or unexplained rectal bleeding

  • if you have severe or persistent vomiting, severe diarrhea, or if you are dehydrated

  • if you are unable to properly absorb glucose from food

Some MEDICINES MAY INTERACT with ReVital Squeezers Solution. However, no specific interactions with ReVital Squeezers Solution are known at this time.


Ask your health care provider if ReVital Squeezers Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use ReVital Squeezers Solution:


Use ReVital Squeezers Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take ReVital Squeezers Solution by mouth with or without food.

  • Do not mix ReVital Squeezers Solution with water or any other liquid.

  • Do not heat ReVital Squeezers Solution.

  • Hold the container gently when cutting the cap off of the attached straw. Holding the container tightly may cause the liquid to spray out.

  • Each container of ReVital Squeezers Solution is intended for a single use. Discard the container and any unused portion of medicine immediately after the first use.

  • Do not reuse the container.

  • If you miss a dose of ReVital Squeezers Solution, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use ReVital Squeezers Solution.



Important safety information:


  • If vomiting, fever, or stomach pain or bloating occurs, or diarrhea continues for longer than 24 hours, check with your doctor.

  • Do not use ReVital Squeezers Solution in CHILDREN younger than 1 year old without first checking with your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using ReVital Squeezers Solution while you are pregnant. It is not known if ReVital Squeezers Solution is found in breast milk. If you are or will be breast-feeding while you use ReVital Squeezers Solution, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of ReVital Squeezers Solution:


All medicines may cause side effects, but many people have no, or minor, side effects. When used in small doses, no COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:



Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: ReVital Squeezers side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of ReVital Squeezers Solution:

Store ReVital Squeezers Solution at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep ReVital Squeezers Solution out of the reach of children and away from pets.


General information:


  • If you have any questions about ReVital Squeezers Solution, please talk with your doctor, pharmacist, or other health care provider.

  • ReVital Squeezers Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about ReVital Squeezers Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More ReVital Squeezers resources


  • ReVital Squeezers Side Effects (in more detail)
  • ReVital Squeezers Support Group
  • 0 Reviews · Be the first to review/rate this drug

Tuesday, 19 July 2011

Enyglid




Enyglid may be available in the countries listed below.


Ingredient matches for Enyglid



Repaglinide

Repaglinide is reported as an ingredient of Enyglid in the following countries:


  • Germany

International Drug Name Search

Sunday, 17 July 2011

Canaural




Canaural may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Canaural



Framycetin

Framycetin sulfate (a derivative of Framycetin) is reported as an ingredient of Canaural in the following countries:


  • Australia

  • Austria

  • Sweden

Fusidic Acid

Fusidic Acid diethanolamine (a derivative of Fusidic Acid) is reported as an ingredient of Canaural in the following countries:


  • Australia

  • Austria

  • Sweden

Nystatin

Nystatin is reported as an ingredient of Canaural in the following countries:


  • Australia

  • Austria

  • Sweden

Prednisolone

Prednisolone is reported as an ingredient of Canaural in the following countries:


  • Australia

  • Austria

  • Sweden

International Drug Name Search

Monday, 4 July 2011

Lévobunolol




Lévobunolol may be available in the countries listed below.


Ingredient matches for Lévobunolol



Levobunolol

Lévobunolol (DCF) is known as Levobunolol in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 2 July 2011

Keimicina




Keimicina may be available in the countries listed below.


Ingredient matches for Keimicina



Kanamycin

Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Keimicina in the following countries:


  • Italy

International Drug Name Search

Sunday, 26 June 2011

Flamagen




Flamagen may be available in the countries listed below.


Ingredient matches for Flamagen



Aldioxa

Aldioxa is reported as an ingredient of Flamagen in the following countries:


  • Japan

International Drug Name Search

Thursday, 23 June 2011

Flucard




Flucard may be available in the countries listed below.


Ingredient matches for Flucard



Fluconazole

Fluconazole is reported as an ingredient of Flucard in the following countries:


  • Japan

International Drug Name Search

Wednesday, 22 June 2011

Skilox




Skilox may be available in the countries listed below.


Ingredient matches for Skilox



Flucloxacillin

Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Skilox in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, 19 June 2011

Diocid-D




Diocid-D may be available in the countries listed below.


Ingredient matches for Diocid-D



Domperidone

Domperidone is reported as an ingredient of Diocid-D in the following countries:


  • India

Omeprazole

Omeprazole is reported as an ingredient of Diocid-D in the following countries:


  • India

International Drug Name Search

Thursday, 16 June 2011

Lokilan




Lokilan may be available in the countries listed below.


Ingredient matches for Lokilan



Flunisolide

Flunisolide is reported as an ingredient of Lokilan in the following countries:


  • Norway

International Drug Name Search

Monday, 13 June 2011

Didanox




Didanox may be available in the countries listed below.


Ingredient matches for Didanox



Didanosine

Didanosine is reported as an ingredient of Didanox in the following countries:


  • Peru

International Drug Name Search

Recombinate


Generic Name: antihemophilic factor (Intravenous route)


an-tee-hee-moe-FIL-ik FAK-tor


Commonly used brand name(s)

In the U.S.


  • Advate

  • Helixate FS

  • Hemofil-M

  • Hyate:C

  • Koate DVI

  • Kogenate FS

  • Kogenate FS w/BIO-SET

  • Monarc-M

  • Monoclate-P

  • Recombinate

  • Refacto

  • Xyntha

Available Dosage Forms:


  • Powder for Solution

Therapeutic Class: Antihemophilic Agent


Uses For Recombinate


Antihemophilic factor (AHF) injection is used to treat serious bleeding episodes in patients with a bleeding problem called hemophilia A. The bleeding episode may be related to an injury (trauma) or a surgical procedure. AHF is a protein that is produced naturally in the body. It helps the blood form clots to stop bleeding and prevents bleeding problems from happening as often.


Hemophilia A, also called classical hemophilia, is a condition where the body does not make enough AHF. If you do not have enough AHF and you become injured, your blood will not form clots properly. You might bleed into and damage your muscles and joints. AHF injection is given to increase the levels of AHF in the blood.


There are several different types of AHF. They are made from human blood or artificially by a man-made process (recombinant). AHF made from human blood has been treated and is not likely to contain harmful viruses, such as hepatitis B, hepatitis C, or human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS). The man-made AHF products do not contain these viruses.


This medicine is available only with your doctor's prescription.


Before Using Recombinate


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of antihemophilic factor injection in children.


No information is available on the relationship of age to the effects of Hemofil® M in the pediatric population. Safety and efficacy have not been established.


Geriatric


Although appropriate studies on the relationship of age to the effects of Advate® have not been performed in the geriatric population, no geriatric-specific problems have been documented to date. However, elderly patients are more likely to have age-related medical problems, which may require caution and an adjustment in the dose for patients receiving Advate®.


No information is available on the relationship of age to the effects of antihemophilic factor injection in geriatric patients.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergy to hamster or mouse proteins, history of or

  • von Willebrand disease—Should not be used in patients with these conditions.

Proper Use of antihemophilic factor

This section provides information on the proper use of a number of products that contain antihemophilic factor. It may not be specific to Recombinate. Please read with care.


A doctor or other trained health professional will give you or your child this medicine in a hospital or clinic setting. This medicine is given through a needle placed in one of your veins.


This medicine may also be given at home to patients who do not need to be in a hospital or clinic. If you or your child are using this medicine at home, your doctor will teach you how to prepare and inject the medicine. Make sure you understand all of the instructions before giving yourself an injection. Your dose may change based on where you are bleeding. Do not use more medicine or use it more often than your doctor tells you to.


Use only the brand of this medicine that your doctor prescribed. Not all brands are prepared in the same way and the dose may be different.


Every package of medicine comes with a patient information leaflet. Read and follow the instructions carefully. Ask your doctor if you have any questions.


To prepare the medicine using 2 bottles (vials) or containers:


  • Take the bottles of powder medicine and liquid (diluent) out of the refrigerator and warm them to room temperature.

  • Wipe the rubber surface of the bottles with an alcohol swab and allow them to dry.

  • Follow the specific directions for your brand of medicine when you prepare the injection.

  • Add the liquid to the powder using the special transfer needle or transfer device that comes with the package.

  • When injecting the liquid into the dry medicine, aim the stream of liquid against the wall of the container of dry medicine to prevent foaming.

  • Swirl the bottle gently to dissolve the medicine. Do not shake the bottle. Shaking will create foam in the mixture.

  • Check the mixture to make sure it is clear. Do not use the medicine if you can see anything solid in the mixture or if the mixture is cloudy.

  • Use a plastic disposable syringe to remove the mixture from the bottle. Use a special filter needle if your brand of medicine provides one.

  • Give the injection as directed by your doctor.

  • If you are using more than one bottle of medicine for your dose, prepare the second bottle the same way. Add the mixture from the second bottle to the same syringe.

To prepare the medicine using a prefilled dual-chamber syringe (Xyntha®):


  • Take the prefilled dual-chamber syringe out of the refrigerator and warm it to room temperature.

  • The dual-chamber syringe has the powder medicine in one part and the liquid (diluent) in the second part of the syringe.

  • Attach the plunger rod to the syringe according to the directions. Keep the syringe pointed up to prevent leaking of the liquid.

  • Remove the white seal and the grey rubber tip cap. Put the blue vented cap on the syringe. Do not touch the open ends of the syringe and the blue cap.

  • Slowly push the plunger until the 2 stoppers inside the syringe are together. This will push all of the liquid into the chamber with the powder medicine.

  • Keep the syringe pointed up and gently swirl the syringe to mix the liquid and powder.

  • Check the mixture to make sure it is clear. Do not use the medicine if you can see anything solid in the mixture or if the mixture is cloudy.

  • Keep the syringe pointed up and push the plunger until most of the air is removed.

  • A special infusion set comes with the package. Remove the blue cap and attach the infusion set to the syringe.

  • Give the injection as directed by your doctor.

  • If you are using more than one syringe of medicine for your dose, prepare the second dual-chamber syringe the same way. The mixture from each syringe will be combined together in a separate syringe before your injection. Your doctor will show you how to do this.

Use the mixture within 3 hours after it is prepared. It must not be stored and used later. Do not put the mixture in the refrigerator.


Do not reuse syringes and needles. Put used syringes and needles in a puncture-resistant disposable container, or dispose of them as directed by your doctor.


Talk to your doctor before traveling. You should plan to bring enough medicine for your treatment when traveling.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form (injection):
    • For bleeding episodes in patients with hemophilia A:
      • Adults and teenagers—Dose is based on body weight and the type of bleeding episode. The dose must be determined by your doctor.

      • Children—Dose is based on body weight and the type of bleeding episode. The dose must be determined by your child's doctor.



Missed Dose


Call your doctor or pharmacist for instructions.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


The AHF products should be stored in the original container in the refrigerator. Do not let the packages freeze. They can also be kept at room temperature for short periods of time, such as 3 to 6 months. Store the medicine as directed by your doctor or by the manufacturer of the brand you are using. Protect the container from heat and direct light.


If you move the medicine from the refrigerator to room temperature, write the date you take it from the refrigerator on the container. The length of time the medicine can remain at room temperature will depend on the brand you use. If you have already stored the medicine at room temperature, do not return it to the refrigerator. If you do not use the medicine within the time recommended by the manufacturer, you must destroy the medicine.


Precautions While Using Recombinate


It is very important that your doctor check you or your child closely while you are receiving this medicine to make sure it is working properly. Blood tests may be needed.


This medicine may cause serious types of allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Stop using this medicine and check with your doctor right away if you or your child have a rash; itching; hoarseness; trouble breathing; trouble swallowing; lightheadedness or dizziness; or any swelling of your hands, face, or mouth after you receive this medicine.


It is recommended that you carry an identification (ID) card or letter stating that you have hemophilia A and the type of medicine you are using. If you have any questions about what kind of identification to carry, check with your doctor.


Check with your doctor right away if you have any symptoms of parvovirus infection: fever, chills, drowsiness, runny nose, and followed by a rash or joint pain.


Check with your doctor right away if you have pain or tenderness in the upper stomach; pale stools; dark urine; loss of appetite; nausea; unusual tiredness or weakness; or yellow eyes or skin. These could be symptoms of a serious liver problem.


This medicine is made from donated human blood. Some human blood products have transmitted certain viruses to people who have received them. The risk of getting a virus from medicines made of human blood has been greatly reduced in recent years. This is the result of required testing of human donors for certain viruses, and testing during manufacture of these medicines. Although the risk is low, talk with your doctor if you have any concerns.


The stopper of the bottle (vial) contains dry natural rubber (a derivative of latex), which may cause allergic reactions in people who are sensitive to latex. Tell your doctor if you have a latex allergy before you start using this medicine.


Recombinate Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Fever

Less common or rare
  • Changes in facial skin color

  • chills

  • fast or irregular breathing

  • nausea

  • puffiness or swelling of the eyelids or around the eyes

  • sensation of burning, warmth, heat, numbness, tightness, or tingling

  • shortness of breath

  • skin rash, hives, or itching

  • tightness in the chest

  • troubled breathing

  • unusual tiredness or weakness

  • wheezing

Incidence not known
  • Bluish color of the fingernails, lips, skin, palms, or nail beds

  • blurred vision

  • chest pain or discomfort

  • confusion

  • cough

  • deep or fast breathing with dizziness

  • difficult or labored breathing

  • difficulty with swallowing

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • fast, pounding, or irregular heartbeat or pulse

  • noisy breathing

  • numbness of the feet, hands, and around the mouth

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • slow or irregular heartbeat

  • sweating

  • swelling of the face, throat, or tongue

  • unusual tiredness or weakness

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Headache

Less common
  • Burning, stinging, or swelling at the place of injection

  • diarrhea

  • dizziness or lightheadedness

  • dry mouth or bad taste in the mouth

  • lack or loss of strength

  • nosebleed

  • redness of the face

  • vomiting

Rare
  • Change in taste

  • loss of taste

Incidence not known
  • Abdominal or stomach pain

  • feeling of warmth

  • increased sweating

  • irritability

  • muscle or bone pain

  • redness of the eye

  • redness of the face, neck, arms, and occasionally, upper chest

  • redness of the skin

  • trouble seeing

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Recombinate side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Recombinate resources


  • Recombinate Side Effects (in more detail)
  • Recombinate Use in Pregnancy & Breastfeeding
  • Recombinate Support Group
  • 0 Reviews for Recombinate - Add your own review/rating


  • Recombinate Prescribing Information (FDA)

  • Antihemophilic Factor Professional Patient Advice (Wolters Kluwer)

  • Advate Consumer Overview

  • Advate Prescribing Information (FDA)

  • Advate MedFacts Consumer Leaflet (Wolters Kluwer)

  • Antihemophilic Factor (Human) Monograph (AHFS DI)

  • Antihemophilic Factor (Recombinant) Monograph (AHFS DI)

  • Helixate FS Prescribing Information (FDA)

  • Kogenate Consumer Overview

  • Kogenate FS MedFacts Consumer Leaflet (Wolters Kluwer)

  • Kogenate FS Prescribing Information (FDA)

  • Monoclate-P Prescribing Information (FDA)

  • Xyntha Prescribing Information (FDA)

  • Xyntha Consumer Overview

  • Xyntha MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Recombinate with other medications


  • Hemophilia A

Wednesday, 8 June 2011

Oberdine




Oberdine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Oberdine



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Oberdine in the following countries:


  • South Africa

International Drug Name Search

Saturday, 28 May 2011

Acido Zoledronico




Acido Zoledronico may be available in the countries listed below.


Ingredient matches for Acido Zoledronico



Zoledronic Acid

Zoledronic Acid is reported as an ingredient of Acido Zoledronico in the following countries:


  • Argentina

  • Peru

International Drug Name Search

Monday, 23 May 2011

Redest




Redest may be available in the countries listed below.


Ingredient matches for Redest



Anastrozole

Anastrozole is reported as an ingredient of Redest in the following countries:


  • India

International Drug Name Search

Friday, 20 May 2011

Ramipril / Piretanid Stada




Ramipril/Piretanid Stada may be available in the countries listed below.


Ingredient matches for Ramipril/Piretanid Stada



Piretanide

Piretanide is reported as an ingredient of Ramipril/Piretanid Stada in the following countries:


  • Germany

Ramipril

Ramipril is reported as an ingredient of Ramipril/Piretanid Stada in the following countries:


  • Germany

International Drug Name Search

Friday, 13 May 2011

Dextrométhorphane Arrow




Dextrométhorphane Arrow may be available in the countries listed below.


Ingredient matches for Dextrométhorphane Arrow



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Dextrométhorphane Arrow in the following countries:


  • France

International Drug Name Search

Sunday, 8 May 2011

Adalat Oros




Adalat Oros may be available in the countries listed below.


Ingredient matches for Adalat Oros



Nifedipine

Nifedipine is reported as an ingredient of Adalat Oros in the following countries:


  • Aruba

  • Bahamas

  • Barbados

  • Belize

  • Bermuda

  • Brazil

  • Bulgaria

  • Cayman Islands

  • Chile

  • Colombia

  • Costa Rica

  • Dominican Republic

  • Ecuador

  • El Salvador

  • Guatemala

  • Haiti

  • Honduras

  • Iceland

  • Indonesia

  • Jamaica

  • Luxembourg

  • Mexico

  • Netherlands Antilles

  • New Zealand

  • Nicaragua

  • Norway

  • Panama

  • Slovenia

  • Suriname

  • Sweden

  • Trinidad & Tobago

International Drug Name Search

Thursday, 5 May 2011

Asparaginase




In some countries, this medicine may only be approved for veterinary use.


In the US, Asparaginase (asparaginase systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphocytic Leukemia.

US matches:

  • Asparaginase

  • Asparaginase Injection

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX02

CAS registry number (Chemical Abstracts Service)

0009015-68-3

Chemical Formula

C1377-H2208-N382-O442-S17

Molecular Weight

31732

Therapeutic Category

Antineoplastic agent

Chemical Name

Enzyme isolated from Escherichia coli, or obtained from other sources

Foreign Names

  • Asparaginase (German)
  • Asparaginase (French)

Generic Names

  • Asparaginase (OS: USAN, DCF)
  • Colaspase (OS: BAN)
  • Crisantaspase (OS: BAN)
  • L-Asparaginase (OS: JAN)
  • A-ase (IS)
  • ASN-ase (IS)
  • L-ASP (IS)
  • L-Asparagine amidohydrolase (IS)
  • NSC 109229 (IS)

Brand Names

  • Asparaginase medac
    Medac, Germany; Medac, Estonia; Medac, Lithuania; Medac, Lithuania; Medac, Malta; Medac, Poland; Medac, Romania


  • Asparaginase
    Medac, Latvia


  • Elspar
    Lundbeck, United States; Merck, United States


  • Erwinase
    Ipsen, Greece; Ipsen, Ireland; NZMS, New Zealand


  • Erwinase (veterinary use)
    Ipsen, United Kingdom


  • Kidrolase
    Aventis, Bulgaria; CTS, Israel; Orphan OPi, France; Thissen, Bulgaria


  • Laspar
    Aspen Pharmacare, South Africa


  • L-Asparaginasa Filaxis
    Filaxis, Argentina


  • L-Asparaginase Medac
    Medac, Greece


  • Leunase
    Aventis, New Zealand; Biochem, India; Kuai Kuai, Taiwan; Kyowa, China; Kyowa, Hong Kong; Kyowa, Sri Lanka; Kyowa, Myanmar; Kyowa, Malaysia; Kyowa, Philippines; Kyowa, Singapore; Kyowa, Thailand; Kyowa Hakko, Indonesia; Kyowa Hakko Kirin, Japan; Kyowa Hakko Kogyo, Vietnam; Onko-Koçsel, Turkey; Sanfer, Mexico; Sanofi-Aventis, Australia


  • Paronal
    Nycomed, Belgium; Nycomed, Netherlands

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Streptomycine




Streptomycine may be available in the countries listed below.


Ingredient matches for Streptomycine



Streptomycin

Streptomycine (DCF) is known as Streptomycin in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 24 April 2011

Acetylcysteine EG




Acetylcysteine EG may be available in the countries listed below.


Ingredient matches for Acetylcysteine EG



Acetylcysteine

Acetylcysteine is reported as an ingredient of Acetylcysteine EG in the following countries:


  • Belgium

International Drug Name Search

Medocel




Medocel may be available in the countries listed below.


Ingredient matches for Medocel



Celecoxib

Celecoxib is reported as an ingredient of Medocel in the following countries:


  • Myanmar

International Drug Name Search

Monday, 18 April 2011

Renoxacin




Renoxacin may be available in the countries listed below.


Ingredient matches for Renoxacin



Norfloxacin

Norfloxacin is reported as an ingredient of Renoxacin in the following countries:


  • Italy

International Drug Name Search

Sunday, 17 April 2011

Betahistine PLIVA




Betahistine PLIVA may be available in the countries listed below.


Ingredient matches for Betahistine PLIVA



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Betahistine PLIVA in the following countries:


  • Poland

  • Slovakia

International Drug Name Search

Friday, 15 April 2011

Antacal




Antacal may be available in the countries listed below.


Ingredient matches for Antacal



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Antacal in the following countries:


  • Italy

International Drug Name Search

Wednesday, 13 April 2011

Optase


Generic Name: balsam Peru, castor oil, and trypsin topical (BAL sum pe ROO, KAS tur oyl, TRIP sin TOP i kal)

Brand Names: Allanderm-T, Granul-Derm, Granulex, Optase, Revina NLT, TBC, Trypsin, Vasolex, Xenaderm


What is balsam Peru, castor oil, and trypsin?

Balsam Peru increases blood flow to a wound area, and also helps fight bacteria.


Castor oil prevents skin cells from breaking down, which aids in wound healing.


Trypsin helps shed damaged skin cells.


The combination of balsam Peru, castor oil, and trypsin topical (for the skin) is used to treat bed sores and other skin ulcers. This medication can help promote healing and relieve pain caused by these conditions.


Balsam Peru, castor oil, and trypsin may also be used for purposes not listed in this medication guide.


What is the most important information I should know about balsam Peru, castor oil, and trypsin?


Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Some forms of this medication are flammable. Do not use near open flame or while you are smoking. Avoid inhaling the spray. Avoid getting this medication in your eyes, mouth, and nose, or on your lips. If it does get into any of these areas, rinse with water.

Use this medication regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.


What should I discuss with my health care provider before using balsam Peru, castor oil, and trypsin?


You should not use this medication if you are allergic to balsam Peru, castor oil, and trypsin. This medication is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether this medication passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use balsam Peru, castor oil, and trypsin?


Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Wash your hands before and after applying this medicine.

Apply a thin layer of medication to the wound. Balsam Peru, castor oil, and trypsin is usually applied at least twice daily. Follow your doctor's instructions.


After applying the medication, you may cover the wound with a bandage dressing, or leave the wound open to the air. Your doctor will tell you whether you should cover the wound or not.

If you need to remove this medication, wash it off with water and mild soap.


Some forms of this medication are flammable. Do not use near open flame or while you are smoking. Avoid inhaling the spray.

Use this medication regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.


Store at room temperature away from moisture and heat. Do not allow the medicine to freeze.

What happens if I miss a dose?


Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using balsam Peru, castor oil, and trypsin?


Avoid getting this medication in your eyes, mouth, and nose, or on your lips. If it does get into any of these areas, rinse with water.

Avoid using skin products that can cause irritation, such as harsh soaps or shampoos or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime.


Avoid using other medications on the areas you treat with balsam Peru, castor oil, and trypsin unless you doctor tells you to.


Balsam Peru, castor oil, and trypsin side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Treating a skin wound may increase your risk of developing an infection in your blood. Call your doctor at once if you have any signs of infection, such as:

  • fever or chills;




  • rapid breathing, gasping for breath;




  • fast heart rate;




  • warmth under your skin; or




  • unusual weakness.



Less serious side effects are more likely, such as mild stinging or burning where the medicine is applied.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect balsam Peru, castor oil, and trypsin?


It is not likely that other drugs you take orally or inject will have an effect on topically applied balsam Peru, castor oil, and trypsin. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Optase resources


  • Optase Use in Pregnancy & Breastfeeding
  • Optase Drug Interactions
  • Optase Support Group
  • 0 Reviews for Optase - Add your own review/rating


  • Granul-Derm Spray MedFacts Consumer Leaflet (Wolters Kluwer)

  • Trypsin

  • Xenaderm Ointment MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Optase with other medications


  • Dermatologic Lesion


Where can I get more information?


  • Your pharmacist can provide more information about balsam Peru, castor oil, and trypsin.


Sunday, 10 April 2011

Renamoca




Renamoca may be available in the countries listed below.


Ingredient matches for Renamoca



Thiamphenicol

Thiamphenicol is reported as an ingredient of Renamoca in the following countries:


  • Indonesia

International Drug Name Search

Saturday, 9 April 2011

Cloperastina




Cloperastina may be available in the countries listed below.


Ingredient matches for Cloperastina



Cloperastine

Cloperastina (DCIT) is also known as Cloperastine (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.